Last reviewed · How we verify

Iodophor (10% povidone-iodine)

University of California, Irvine · FDA-approved active Small molecule

Povidone-iodine releases iodine that oxidizes and denatures microbial proteins and nucleic acids, providing broad-spectrum antimicrobial activity.

Povidone-iodine releases iodine that oxidizes and denatures microbial proteins and nucleic acids, providing broad-spectrum antimicrobial activity. Used for Skin antisepsis and wound disinfection, Surgical site preparation, Minor cuts, scrapes, and burns.

At a glance

Generic nameIodophor (10% povidone-iodine)
SponsorUniversity of California, Irvine
Drug classTopical antiseptic/disinfectant
ModalitySmall molecule
Therapeutic areaInfection prevention and control
PhaseFDA-approved

Mechanism of action

The iodine component penetrates microbial cell membranes and oxidizes essential proteins, enzymes, and DNA/RNA, leading to rapid cell death. This mechanism is effective against bacteria, viruses, fungi, and some protozoa. The povidone carrier enhances stability and sustained release of iodine at the site of application.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results